Castleview Partners, LLC Mimedx Group, Inc. Transaction History

Castleview Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$6.35 - $8.16 $88,265 - $113,424	-13,900 Reduced 98.09%	270 $1,000
Q1 2023 May 15, 2023	SELL	$2.97 - $4.81 $5,940 - $9,620	-2,000 Reduced 12.37%	14,170 $48,000
Q3 2022 Nov 10, 2022	BUY	$2.71 - $4.22 $35,509 - $55,294	13,103 Added 427.23%	16,170 $46,000
Q2 2022 Aug 17, 2022	SELL	$3.17 - $5.0 $467,143 - $736,820	-147,364 Reduced 97.96%	3,067 $10,000
Q2 2022 Aug 16, 2022	BUY	$3.17 - $5.0 $339,440 - $535,395	107,079 Added 247.0%	150,431 $521,000
Q1 2022 May 16, 2022	SELL	$4.27 - $6.27 $906,273 - $1.33 Million	-212,242 Reduced 83.04%	43,352 $204,000
Q4 2021 Feb 17, 2022	BUY	$5.7 - $8.48 $1.15 Million - $1.71 Million	201,511 Added 372.6%	255,594 $1.54 Million
Q2 2021 Aug 17, 2021	SELL	$9.02 - $12.72 $14,973 - $21,115	-1,660 Reduced 2.98%	54,083 $677,000
Q1 2018 May 07, 2018	BUY	$6.69 - $17.96 $372,920 - $1 Million	55,743 New	55,743 $389,000

221

98.1M

38.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $953M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.